This topic contains a solution. Click here to go to the answer

Author Question: ________ is a Swedish smokeless tobacco product that has been successfully marketed as a harm ... (Read 256 times)

nevelica

  • Hero Member
  • *****
  • Posts: 563
________ is a Swedish smokeless tobacco product that has been successfully marketed as a harm reduction product..
 
  a. The electronic cigarette
  b. The blunt
  c. Snus
  d. Omni

Question 2

The focus of the harm reduction approach to nicotine dependence is to _________.
 
  a. eliminate nicotine use entirely
  b. reduce smoking to a standardized healthy level
  c. eliminate or reduce the negative consequences of nicotine use
  d. encourage smokers to switch to healthier methods of nicotine use, such as nicotine gum



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

zoeyesther

  • Sr. Member
  • ****
  • Posts: 315
Answer to Question 1

c

Answer to Question 2

c




nevelica

  • Member
  • Posts: 563
Reply 2 on: Jun 22, 2018
Thanks for the timely response, appreciate it


AngeliqueG

  • Member
  • Posts: 343
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

When taking monoamine oxidase inhibitors, people should avoid a variety of foods, which include alcoholic beverages, bean curd, broad (fava) bean pods, cheese, fish, ginseng, protein extracts, meat, sauerkraut, shrimp paste, soups, and yeast.

Did you know?

There are more bacteria in your mouth than there are people in the world.

Did you know?

It is widely believed that giving a daily oral dose of aspirin to heart attack patients improves their chances of survival because the aspirin blocks the formation of new blood clots.

Did you know?

Oxytocin is recommended only for pregnancies that have a medical reason for inducing labor (such as eclampsia) and is not recommended for elective procedures or for making the birthing process more convenient.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library